X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (12911) 12911
Newspaper Article (1076) 1076
Magazine Article (109) 109
Newsletter (87) 87
Book / eBook (65) 65
Book Chapter (58) 58
Dissertation (39) 39
Web Resource (27) 27
Trade Publication Article (23) 23
Government Document (18) 18
Reference (9) 9
Conference Proceeding (8) 8
Report (4) 4
Book Review (2) 2
Paper (2) 2
Publication (2) 2
Transcript (2) 2
Journal / eJournal (1) 1
Video Recording (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (9584) 9584
nicotine (8513) 8513
male (5984) 5984
female (5943) 5943
smoking (5916) 5916
adult (4301) 4301
tobacco (3476) 3476
smoking - adverse effects (3464) 3464
nicotine - adverse effects (2935) 2935
smoking cessation (2862) 2862
middle aged (2815) 2815
animals (2512) 2512
cigarette-smoking (2123) 2123
psychiatry (1863) 1863
adolescent (1814) 1814
risk factors (1812) 1812
electronic cigarettes (1758) 1758
cigarettes (1693) 1693
public, environmental & occupational health (1678) 1678
pregnancy (1657) 1657
substance abuse (1613) 1613
smoking cessation - methods (1605) 1605
nicotine - administration & dosage (1592) 1592
smokers (1514) 1514
pharmacology & pharmacy (1464) 1464
research (1349) 1349
health aspects (1343) 1343
young adult (1325) 1325
neurosciences (1268) 1268
rats (1245) 1245
public health (1234) 1234
aged (1217) 1217
cigarette smoking (1163) 1163
nicotine dependence (1145) 1145
nicotine - pharmacology (1104) 1104
smoking - epidemiology (1100) 1100
cessation (1098) 1098
analysis (1095) 1095
smoking - psychology (1085) 1085
exposure (995) 995
medicine, general & internal (922) 922
smoking cessation programs (922) 922
risk (913) 913
smoking prevention (870) 870
studies (843) 843
toxicology (802) 802
tobacco smoke pollution - adverse effects (771) 771
surveys and questionnaires (729) 729
time factors (722) 722
smoking cessation - psychology (718) 718
prevalence (714) 714
nicotine replacement therapy (706) 706
treatment outcome (698) 698
medicine (687) 687
smoking-cessation (683) 683
addiction (670) 670
dependence (667) 667
cotinine (661) 661
alcohol (646) 646
dose-response relationship, drug (625) 625
mice (620) 620
child (604) 604
cancer (581) 581
usa (577) 577
behavior (573) 573
nicotine - therapeutic use (547) 547
nicotinic agonists - adverse effects (545) 545
united-states (545) 545
health (541) 541
abridged index medicus (533) 533
care and treatment (533) 533
united states (527) 527
cross-sectional studies (523) 523
smoke (521) 521
adults (511) 511
tobacco industry (505) 505
usage (503) 503
passive smoking (502) 502
nicotine - toxicity (501) 501
electronic nicotine delivery systems (497) 497
varenicline (495) 495
rats, sprague-dawley (493) 493
research article (491) 491
epidemiology (487) 487
double-blind method (482) 482
tobacco smoke (478) 478
mortality (474) 474
nicotinic agonists - administration & dosage (473) 473
respiratory system (471) 471
brain (469) 469
maternal smoking (459) 459
children (456) 456
disease (453) 453
tobacco use disorder - psychology (452) 452
drug addiction (451) 451
withdrawal (450) 450
follow-up studies (449) 449
pediatrics (448) 448
psychology, clinical (448) 448
prospective studies (431) 431
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (36) 36
Online Resources - Online (18) 18
Robarts - Stacks (13) 13
UofT at Mississauga - Stacks (9) 9
UofT at Scarborough - Stacks (7) 7
Collection Dvlpm't (Acquisitions) - Vendor file (5) 5
UTL at Downsview - May be requested (3) 3
Collection Dvlpm't (Acquisitions) - Closed Orders (2) 2
New College (Ivey) - Stacks (2) 2
Dentistry (Harry R Abbott) - Stacks (1) 1
Gerstein Science - Bindery (1) 1
Gerstein Science - Library use only (1) 1
Gerstein Science - Missing (1) 1
Gerstein Science - Periodical Stacks (1) 1
New College (Ivey) - Withdrawn (1) 1
OISE - Stacks (1) 1
University College (Laidlaw) - Stacks (1) 1
Victoria University E.J. Pratt - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (13884) 13884
German (177) 177
French (129) 129
Spanish (70) 70
Polish (61) 61
Japanese (56) 56
Portuguese (40) 40
Russian (38) 38
Italian (26) 26
Swedish (25) 25
Chinese (19) 19
Danish (18) 18
Dutch (13) 13
Norwegian (11) 11
Romanian (9) 9
Hungarian (8) 8
Finnish (7) 7
Turkish (5) 5
Czech (3) 3
Bulgarian (2) 2
Icelandic (2) 2
Korean (2) 2
Persian (2) 2
Arabic (1) 1
Croatian (1) 1
Dzongkha (1) 1
Greek (1) 1
Hebrew (1) 1
Serbian (1) 1
Thai (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cochrane library, ISSN 1465-1858, 2016, Volume 2016, Issue 5, p. CD006103
Background Nicotine receptor partial agonists may help people to stop smoking by a combination of maintaining moderate levels of dopamine to counteract... 
Interventions to help smokers and other tobacco users to quit | Lungs & airways | Pharmacological interventions | Varenicline | Substance Withdrawal Syndrome | Azepines | Randomized Controlled Trials as Topic | Heterocyclic Compounds, 4 or More Rings | Alkaloids | Quinolizines | Tobacco, drugs & alcohol | By treatment type | Tobacco | Azocines | Bupropion | Benzazepines | Nicotinic Agonists | Counseling | Medications | Medicine General & Introductory Medical Sciences | Nicotine | Smoking | Smoking Cessation | Smoking [drug therapy] | Humans | RANDOMIZED CONTROLLED-TRIAL | Quinolizines [therapeutic use] | PSYCHIATRIC ADVERSE EVENTS | TOBACCO-DEPENDENCE TREATMENT | Quinoxalines [therapeutic use] | MEDICINE, GENERAL & INTERNAL | Bupropion [therapeutic use] | Nicotine [adverse effects; antagonists & inhibitors] | REPLACEMENT THERAPY | SUSTAINED-RELEASE BUPROPION | Smoking Cessation [methods] | Counseling [methods] | VARENICLINE TREATMENT | METHADONE-MAINTAINED SMOKERS | Azepines [therapeutic use] | DOUBLE-BLIND PLACEBO | Alkaloids [therapeutic use] | Nicotinic Agonists [adverse effects; therapeutic use] | Azocines [therapeutic use] | LONG-TERM SAFETY | Benzazepines [therapeutic use] | PLACEBO-CONTROLLED TRIAL | Substance Withdrawal Syndrome [prevention & control] | Heterocyclic Compounds with 4 or More Rings [therapeutic use] | Quinolizines - therapeutic use | Azepines - adverse effects | Azocines - therapeutic use | Azocines - adverse effects | Substance Withdrawal Syndrome - prevention & control | Alkaloids - adverse effects | Benzazepines - adverse effects | Smoking - drug therapy | Heterocyclic Compounds, 4 or More Rings - adverse effects | Nicotinic Agonists - therapeutic use | Nicotine - antagonists & inhibitors | Smoking Cessation - methods | Azepines - therapeutic use | Nicotine - adverse effects | Nicotinic Agonists - adverse effects | Heterocyclic Compounds, 4 or More Rings - therapeutic use | Benzazepines - therapeutic use | Counseling - methods | Alkaloids - therapeutic use | Quinolizines - adverse effects | Varenicline - therapeutic use | Bupropion - therapeutic use
Journal Article
European Archives of Psychiatry and Clinical Neuroscience, ISSN 0940-1334, 4/2006, Volume 256, Issue 3, pp. 174 - 186
Journal Article
Inhalation Toxicology, ISSN 0895-8378, 10/2012, Volume 24, Issue 12, pp. 850 - 857
Context: Electronic cigarettes (e-cigarettes) have earned considerable attention recently as an alternative to smoking tobacco, but uncertainties about their... 
toxicity | risk assessment | nicotine vaporizer | indoor air quality | glycerine | exposure assessment | ecig | TSNA | secondhand vapor | emissions | SHS | SHV | tobacco smoke | vapor | ecigarette | DEG | VOC | inhalation | carbonyl | e-liquid | PAH | E-cigarette | cancer risk | vaping | risk estimate | e-cig | eliquid | Vapor | Toxicity | Cancer risk | Ecigarette | Risk assessment | Eliquid | E-cig | Indoor air quality | Tobacco smoke | Glycerine | Nicotine vaporizer | Carbonyl | Emissions | Inhalation | Vaping | E-liquid | Risk estimate | Ecig | Secondhand vapor | Exposure assessment | NICOTINE | CESSATION | ELECTRONIC CIGARETTES | TOXICOLOGY | DEVICE E-CIGARETTE | BREATH | VOLATILE ORGANIC-COMPOUNDS | Air Pollution, Indoor - analysis | Particulate Matter - toxicity | Air Pollutants - analysis | Nicotine - administration & dosage | Polycyclic Aromatic Hydrocarbons - toxicity | Humans | Materials Testing - instrumentation | Polycyclic Aromatic Hydrocarbons - administration & dosage | Glycols - analysis | Nicotine - adverse effects | Nicotine - analysis | Glycols - adverse effects | Volatile Organic Compounds - administration & dosage | Aldehydes - analysis | Volatilization | Nitrosamines - administration & dosage | Inhalation Exposure - adverse effects | Adult | Glycols - administration & dosage | Child | Aldehydes - toxicity | Risk Assessment | Electrical Equipment and Supplies - adverse effects | Particulate Matter - adverse effects | Tobacco Use Cessation Products - adverse effects | Volatile Organic Compounds - analysis | Nitrosamines - toxicity | Nitrosamines - analysis | Aldehydes - administration & dosage | Particle Size | Particulate Matter - analysis | Tobacco Smoke Pollution - adverse effects | Volatile Organic Compounds - adverse effects | Polycyclic Aromatic Hydrocarbons - analysis | Air Pollutants - adverse effects | Air Pollutants - toxicity | Tobacco Smoke Pollution - analysis | Air Pollution, Indoor - adverse effects | Particulate Matter - administration & dosage
Journal Article
Canadian Medical Association journal (CMAJ), ISSN 0820-3946, 09/2011, Volume 183, Issue 12, pp. 1359 - 1366
Journal Article